Disease Areas
Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery
Second Genome aims to identify a composite biomarker for the noninvasive diagnosis of nonalcoholic steatohepatitis patients with advanced fibrosis.
Aviv Scientific Closes $40M Series B Financing Round
The company plans to use the funds to roll out a database containing comprehensive omics data that captures the aging process in healthy adults.
Genomenon, Alexion Pharmaceuticals Team on Rare Disease Dx
Genomenon will apply its AI-driven technology to develop a "genomic landscape" for specific conditions and combine those data with therapy and trial information.
DiaSorin Molecular Receives CE Mark for Multiplex COVID-19, Influenza Test
The test detects and differentiates between nucleic acids from SARS-CoV-2 and influenza A/B from the same sample in one reaction well.
The technology has been licensed by MGeneRx, which plans to commercialize it in the US first, then expand to low- and middle-income countries.
Sep 9, 2021
Sep 9, 2021
Sep 7, 2021